Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. - Wikidata - wikimedia - TriplyDB

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.

http://www.wikidata.org/entity/Q36924964

about

Recent advances in managing and understanding diabetic nephropathy Vitamin D and Diabetic Complications: True or False Prophet?Effect of Vitamin D Receptor Activators on Glomerular Filtration Rate: A Meta-Analysis and Systematic Review Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system Review article: vitamin D and inflammatory bowel disease--established concepts and future directions Diabetic kidney disease: from physiology to therapeutics Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy Urinary albumin : creatinine ratio predicts prediabetes progression to diabetes and reversal to normoglycemia: role of associated insulin resistance, inflammatory cytokines and low vitamin D Renoprotective effects of long-term oral nicotine in a rat model of spontaneous proteinuria The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system.Vitamin D: newly discovered actions require reconsideration of physiologic requirements.PLK2 Plays an Essential Role in High D-Glucose-Induced Apoptosis, ROS Generation and Inflammation in Podocytes.Vitamin D and chronic kidney disease Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system.Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.Juxtaglomerular apparatus hyperplasia under dual angiotensin blockade. A footprint of adequate RAS inhibition or a concern for renal fibrosis?Diabetic nephropathy - complications and treatment.Effect of vitamin-D analogue on albuminuria in patients with non-dialysed chronic kidney disease stage 4-5: a retrospective single center study.Emerging drugs for chronic kidney disease.Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study.Oral supplementation with cholecalciferol 800 IU ameliorates albuminuria in Chinese type 2 diabetic patients with nephropathy Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency?Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism Multiple genes of the renin-angiotensin system are novel targets of Wnt/β-catenin signaling.Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney disease The effect on quality of life of vitamin D administration for advanced cancer treatment (VIDAFACT study): protocol of a randomised controlled trial.Active vitamin D treatment for reduction of residual proteinuria: a systematic review.Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study Vitamin d receptor activators and clinical outcomes in chronic kidney disease.Nuclear receptors in renal disease Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension.Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease Molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression Podocyte biology for the bedside The use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism.The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitus Vitamin D therapy in chronic kidney disease and end stage renal disease.The kidney in type 2 diabetes therapy

P2860

Q26745900-462A3822-6782-4100-B2D5-51340BA3E3B3 Q26766181-BB87B646-EA9C-4BF9-BD8D-9BB6460064EB Q26774371-D4B2D601-8539-45D8-941F-DDCFFB0A541B Q26822500-212A3C0D-D72D-400E-A94B-7052DC3B1754 Q27015639-3D190D90-EFEC-430A-9FC2-38504110CEB6 Q27021392-05EDA6FC-C937-4643-A8CD-8631379B8343 Q28258849-5AAB4F53-3086-4572-BBAD-A0B80AFF66D6 Q28302247-6C145D56-0942-4A56-92F9-E73D2DD34906 Q28583340-BB86A990-B99F-4D67-B9AA-71D92221DBF8 Q30426517-92FAC8BA-CB08-4AB0-8DC3-768A599E06CD Q33530770-BDF0DBF0-3DCC-48E3-A0DD-121B273FB21B Q33842977-C1774AEC-4953-4239-B96F-E35E65FBCDEE Q33885968-740E7168-84C9-4B2E-8AB5-DE3FE3C465F5 Q33979345-B7DDED20-737E-4FFB-94CB-D4EE34A92B4D Q34032089-4C19F914-448D-4788-B4B4-9191464D778E Q34245670-523BF4DA-BF75-4291-8230-D3E9C073B5E9 Q34387952-0F0189F3-31E9-4E77-AECE-B7802AEE9B0D Q34408823-18E9701D-CCE4-4CB4-9BC7-478BFA075AC1 Q34420383-374F6DD8-DAA7-410F-A657-6D9A1BD813E3 Q34457259-93DFFACC-1921-475B-9AD5-C3DB3A5E0010 Q34483554-0023501F-68AE-4016-922E-3DC750441FB7 Q34500399-2F3BE2C9-D8FA-44C6-A02C-30DC2AAA91D9 Q34571836-39F5E14A-97A5-4DBF-AA1B-0085977CB756 Q34604473-25C52E77-651F-41FD-95D9-5A3C7FD686A9 Q34719267-87933D71-36AE-478E-AA39-61006C371540 Q34787805-30AD82A2-DAAE-43D3-95CD-CC5116ED3318 Q34797562-2B3D613A-C1A8-42A3-B89E-B528006BB738 Q34799604-6B5694E9-4426-4052-B742-02ECE0C2B150 Q34912750-7BBE0D89-26F4-4D77-AB70-6E60100D3F1D Q34967905-82DE04CC-D8EE-46FA-B097-BDB54FA53D0A Q35020986-8D337298-9C89-4112-B353-1334C456724E Q35120702-761E6948-320F-464E-A2E6-763AC45DBC7F Q35137622-2AFAC009-63D4-4BE0-9C3F-D9BF73352FB4 Q35210184-36B1FA9A-320F-4320-827C-5B23B178BEBC Q35213312-7F0D9B5D-ED39-48F2-94C9-6F0F769A0DF4 Q35256633-742F7094-C11C-4C38-9833-7540DBF461C4 Q35573698-D6B7B776-6462-4A10-A221-CBF2FD1916D1 Q35673714-A0915C6F-0F1E-431A-B05B-679642802BBC Q35758581-47870441-8118-4244-B95A-332F1B474433 Q35760302-3A732FF2-89A1-4349-9E60-8156AEE91567

P2860

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.

http://www.wikidata.org/entity/Q36924964

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Combination therapy with AT1 b ...... f compensatory renin increase.

@en

type

label

Combination therapy with AT1 b ...... f compensatory renin increase.

@en

prefLabel

Combination therapy with AT1 b ...... f compensatory renin increase.

@en

P1433

Q36924964-0BD29F41-1E67-4D17-9B92-5B152D2F29C8

P1476

Q36924964-B916118F-79FA-4132-8680-2AB615B5680E

P2093

Q36924964-5FDA2676-D4B4-4D02-A949-0EDED5915025

Q36924964-9D8D0B70-ADD0-4F1C-AAEF-A80C3FB446FB

Q36924964-AE0D7DFF-1908-46F2-8780-1EAEC91903AE

Q36924964-BFE5D32B-2DFF-4DA9-893E-AB022B181C7B

Q36924964-DDBE38BE-8AD9-43B8-A64D-ECB81EE9F3ED

Q36924964-EEBBC18F-E956-490A-A5BE-960B40340486

P2860

Q36924964-002416D6-F6B8-4BA0-9553-74D6E489BFEF

Q36924964-030CD259-43CE-41B2-AD05-77238F48CE74

Q36924964-032BB9C1-99DB-46B0-B528-9326EF9C7D49

Q36924964-064C5F52-DEB3-47D1-AC3D-A4B870CA6037

Q36924964-17E19B24-BAC7-4056-A4CC-C77619C8417F

Q36924964-1BA8E5D5-6C37-48AD-B1DD-8E476188F28A

Q36924964-1BAE0AD3-FFAD-4F82-920A-BB165C8F4DAA

Q36924964-2DF63AB8-E531-4330-B8B8-06F3B8C9A626

Q36924964-2F8367FE-CA88-4D08-94D1-C96D0C62E9A5

Q36924964-4035534A-30E1-44B2-800E-BFACD389B34A

P304

Q36924964-7A13221C-F637-4A7F-9CAC-5AF9948E2479

P31

Q36924964-C317FE3E-6180-4403-9B07-170DA38FC42F

P356

Q36924964-481183E5-2A5A-418E-A603-53630C29089B

P407

Q36924964-29D08F14-2BA7-43F2-8ABE-C7AC58328426

P433

Q36924964-236EE331-41DA-4C6C-B80A-8AD1F392FA22

P478

Q36924964-70E6CF14-6FA0-442D-ABBA-7AAE6478557E

P577

Q36924964-89974F8B-F832-46AC-B979-2600C6F077BE

P5875

Q36924964-A5F5B00C-ED8C-4937-B046-F6A1105029F3

P698

Q36924964-D35EEFCC-CBA0-4AF2-9E57-BBC33A70C655

P921

Q36924964-AD317166-51D0-4989-A517-6213D82ED706

P932

Q36924964-57BA659B-FAB4-4CDE-B043-A98CBC8A4CE0

P356

PNAS.0803751105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Combination therapy with AT1 b ...... f compensatory renin increase.

@en

P2093

Dilip K Deb

http://www.w3.org/2001/XMLSchema#string

Gang Ning

http://www.w3.org/2001/XMLSchema#string

Juan Kong

http://www.w3.org/2001/XMLSchema#string

Yan Chun Li

http://www.w3.org/2001/XMLSchema#string

Yan Zhang

http://www.w3.org/2001/XMLSchema#string

Zhongyi Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

The intrarenal renin-angiotensin system and diabetic nephropathy.

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

Diabetic nephropathy: diagnosis, prevention, and treatment.

Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats.

P304

15896-15901

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0803751105

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23303134

http://www.w3.org/2001/XMLSchema#string

P698

18838678

http://www.w3.org/2001/XMLSchema#string

P921

P932

2562415

http://www.w3.org/2001/XMLSchema#string